Alcon (MEX:ALC N) Research & Development: MXN18,533 Mil (TTM As of Mar. 2026)


MEX:ALC N Alcon Inc MEX:ALC N
73 GF Score
Price MXN1,158.62
GF Value MXN1,530.81
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Alcon Research & Development?

Alcon MEX:ALC N 73 Research & Development is MXN18,533 Mil as of Mar. 2026. GuruFocus rates MEX:ALC N with a GF Score™ of 73/100 and a GF Value™ of MXN1,530.81 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Alcon's Research & Development for the three months ended in Mar. 2026 was MXN4,418 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was MXN18,533 Mil.

Alcon  (MEX:ALC N) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Alcon Research & Development Related Terms

Alcon Research & Development Historical Data

* Premium members only.

The historical data trend for Alcon's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alcon Research & Development Chart

Alcon Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17,272.79 13,686.19 14,054.68 18,269.59 17,825.64

Alcon Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,541.72 4,613.15 4,586.05 4,915.56 4,418.01
MEX:ALC N
73GF Score
Alcon Inc MEX:ALC N
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alcon Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN18,533 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of MXN18,533 Mil mean?
Alcon (MEX:ALC N) has a Research & Development of MXN18,533 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Alcon and its competitors.
Is Alcon's Research & Development too high?
Alcon's current Research & Development is MXN18,533 Mil. Overall, Alcon has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alcon's Research & Development compare to ISRG and BDX?
Alcon's Research & Development of MXN18,533 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Alcon and its competitors. Alcon's current Research & Development is MXN18,533 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alcon stock overvalued right now?
Based on GuruFocus' analysis, Alcon (MEX:ALC N) is currently considered Significantly Undervalued. The stock's GF Value™ is MXN1,530.81, compared to a current price of MXN1,158.62 — trading 24.3% below its estimated fair value. The current Research & Development is MXN18,533 Mil. Alcon's overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Alcon (MEX:ALC N), the current Research & Development is MXN18,533 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alcon (MEX:ALC N) Overvalued in 2026?

Based on GuruFocus' analysis, Alcon stock appears to be undervalued. The current stock price of MXN1,158.62 is trading 24.3% below its estimated GF Value™ of MXN1,530.81. GuruFocus considers Alcon to be Significantly Undervalued.

Key valuation signals for MEX:ALC N:

  • Research & Development: MXN18,533 Mil
  • GF Value™: MXN1,530.81 vs. price of MXN1,158.62 (24.3% below fair value)
  • GF Score™: 73/100 with 3 warning signs

No single metric tells the full story. See the MEX:ALC N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Alcon Business Description

Address Chemin de Blandonnet 8, Vernier, Geneva, CHE, 1214
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
73GF Score

Get the complete analysis for MEX:ALC N

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,158.62
Price
MXN1,530.81
GF Value